Gemina Laboratories Ltd. (CSE:GLAB)
Canada flag Canada · Delayed Price · Currency is CAD
0.7500
+0.0700 (10.29%)
Jul 30, 2025, 3:56 PM EDT

Splunk Income Statement

Millions CAD. Fiscal year is Feb - Jan.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '25 Jan '25 Jan '24 Jan '23 Jan '22 Jan '21
Selling, General & Admin
2.52.642.611.81.990.18
Research & Development
1.331.282.594.152.710.49
Operating Expenses
3.833.915.25.984.730.67
Operating Income
-3.81-3.91-5.2-5.98-4.73-0.67
Interest Expense
-0.17-0.16-0.02--0-0
Other Non Operating Income (Expenses)
-0.03--0--
EBT Excluding Unusual Items
-4.01-4.08-5.22-5.98-4.73-0.67
Gain (Loss) on Sale of Assets
-0.02-0.02----
Other Unusual Items
0.020.02----0.44
Pretax Income
-4.01-4.07-5.22-5.98-4.73-1.11
Net Income
-4.01-4.07-5.22-5.98-4.73-1.11
Net Income to Common
-4.01-4.07-5.22-5.98-4.73-1.11
Shares Outstanding (Basic)
757472604834
Shares Outstanding (Diluted)
757472604834
Shares Change (YoY)
2.03%2.22%20.37%26.30%41.35%-
EPS (Basic)
-0.05-0.06-0.07-0.10-0.10-0.03
EPS (Diluted)
-0.05-0.06-0.07-0.10-0.10-0.03
Free Cash Flow
-0.47-1.3-3.29-4.59-3.88-0.43
Free Cash Flow Per Share
-0.01-0.02-0.04-0.08-0.08-0.01
EBITDA
-3.8-3.9-5.18-5.97-4.72-
D&A For EBITDA
0.010.020.020.010.01-
EBIT
-3.81-3.91-5.2-5.98-4.73-0.67
Source: S&P Global Market Intelligence. Standard template. Financial Sources.